CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 7 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $604,904 | +42.2% | 9,663 | +3.1% | 0.10% | +29.3% |
| Q3 2023 | $425,531 | +957.2% | 9,375 | +1207.5% | 0.08% | +525.0% |
| Q2 2023 | $40,252 | -89.9% | 717 | -91.9% | 0.01% | -82.6% |
| Q1 2023 | $400,286 | +2.9% | 8,850 | +17.2% | 0.07% | +155.6% |
| Q4 2022 | $388,849 | +3.1% | 7,549 | +1.5% | 0.03% | -3.6% |
| Q3 2022 | $377,000 | -1.3% | 7,440 | -3.4% | 0.03% | +3.7% |
| Q1 2022 | $382,000 | – | 7,699 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |